12-6445103-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001242.5(CD27):​c.8G>A​(p.Arg3Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000467 in 1,604,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000047 ( 0 hom. )

Consequence

CD27
NM_001242.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.0640

Publications

0 publications found
Variant links:
Genes affected
CD27 (HGNC:11922): (CD27 molecule) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [provided by RefSeq, Jul 2008]
CD27-AS1 (HGNC:43896): (CD27 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07768902).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD27NM_001242.5 linkc.8G>A p.Arg3Gln missense_variant Exon 1 of 6 ENST00000266557.4 NP_001233.2 P26842

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD27ENST00000266557.4 linkc.8G>A p.Arg3Gln missense_variant Exon 1 of 6 1 NM_001242.5 ENSP00000266557.3 P26842

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152130
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000560
AC:
13
AN:
231998
AF XY:
0.0000713
show subpopulations
Gnomad AFR exome
AF:
0.0000684
Gnomad AMR exome
AF:
0.0000314
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000583
Gnomad FIN exome
AF:
0.000101
Gnomad NFE exome
AF:
0.0000768
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000468
AC:
68
AN:
1452282
Hom.:
0
Cov.:
31
AF XY:
0.0000499
AC XY:
36
AN XY:
721886
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33196
American (AMR)
AF:
0.0000235
AC:
1
AN:
42544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25880
East Asian (EAS)
AF:
0.0000761
AC:
3
AN:
39444
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85010
European-Finnish (FIN)
AF:
0.000152
AC:
8
AN:
52714
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5128
European-Non Finnish (NFE)
AF:
0.0000478
AC:
53
AN:
1108490
Other (OTH)
AF:
0.0000334
AC:
2
AN:
59876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152130
Hom.:
0
Cov.:
31
AF XY:
0.0000538
AC XY:
4
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41438
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000495
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 19, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.8G>A (p.R3Q) alteration is located in exon 1 (coding exon 1) of the CD27 gene. This alteration results from a G to A substitution at nucleotide position 8, causing the arginine (R) at amino acid position 3 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Lymphoproliferative syndrome 2 Uncertain:1
Jul 20, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 3 of the CD27 protein (p.Arg3Gln). This variant is present in population databases (rs776469650, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CD27-related conditions. ClinVar contains an entry for this variant (Variation ID: 1060135). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
12
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.37
T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.078
T
MetaSVM
Benign
-0.30
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.064
PrimateAI
Benign
0.20
T
PROVEAN
Benign
0.10
N
REVEL
Benign
0.13
Sift
Benign
0.34
T
Sift4G
Benign
0.36
T
Polyphen
0.037
B
Vest4
0.048
MutPred
0.47
Gain of catalytic residue at W7 (P = 6e-04);
MVP
0.92
MPC
0.21
ClinPred
0.035
T
GERP RS
1.9
PromoterAI
-0.00010
Neutral
Varity_R
0.029
gMVP
0.34
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776469650; hg19: chr12-6554269; API